Last reviewed · How we verify
NCT06235333
Exploring a Lottery-promoted Gambling Disorder Screening Day Intervention
NA trial testing Gambling Disorder Screening Day screener in Gambling Problem in 4,500 participants. Status unknown.
12 June 2024
Quick facts
| Lead sponsor | Cambridge Health Alliance |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 4,500 |
| Start date | 12 March 2024 |
| Primary completion | 12 June 2024 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- Gambling Disorder Screening Day screener
- Gambling Disorder Screening Day information sheet
Conditions studied
- Gambling Problem — all drugs for Gambling Problem →
Sponsor
Cambridge Health Alliance — full company profile →
Who can join
Adults 18 to 100, any sex, with Gambling Problem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a randomized trial of gambling screening plus feedback (intervention) or gambling information (control) conditions, with data collection at baseline (T1) and a 3-month follow-up (T2). Two participant recruitment strategies (i.e., Hoosier Lottery cohort and MTurk Workers cohort) will allow the investigators to compare how recruitment source relates to post-intervention gambling behavior change intentions and assorted gambling-related behavior changes. The investigators also seek to understand how experiences with screening vary for minoritized and non-minoritized people who gamble.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06235333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cambridge Health Alliance trials
Trials by the same sponsor.
- NCT06419595 — Screening and Support for Youth (SASY) · NA · not yet recruiting
- NCT07513220 — The Effectiveness and Acceptability of Formal Versus Informal Mindful Self-Compassion for Adolescents · NA · not yet recruiting
- NCT06988462 — Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food · NA · recruiting
- NCT06564948 — Treatment for Individuals Interacting with the Criminal Justice System · NA · recruiting
- NCT06765122 — Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06235333 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cambridge Health Alliance
- Last refreshed: 31 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06235333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing